Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients
Primary Purpose
Type 2 Diabetes, Insulin Resistance
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Fish Oil Supplementation
Flaxseed Oil Supplementation
placebo
Sponsored by
About this trial
This is an interventional supportive care trial for Type 2 Diabetes focused on measuring omega-3 fatty acids, randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
- Fasting glucose > 7.0 or have diabetes medication;
- Male, 35-80 years; female, postmenopausal to 80 years;
- Agree to participant in the trial.
Exclusion Criteria:
- Deny to sign the informed consent;
- type 1 diabetes;
- Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L;
- Have severe liver disease, kidney disease or cancer;
- Participating in the other clinical trial within 30 days;
- Other diseases or conditions, for which the doctor of the patients do not agree his or her participating.
Sites / Locations
- Zhejiang University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Placebo Comparator
Arm Label
Fish Oil Supplementation
Flaxseed Oil Supplementation
Placebo Supplementation
Arm Description
Patients will receive fish oil capsules, at a dose of 4g/day. Each 1g capsule will contain 300mg of EPA and 200mg of DHA.
Patients will receive flaxseed oil capsule, at a dose of 4g/day. Each 1g capsule will contain 630mg of ALA
Patients will receive corn oil in the capsules at the same dose as fish oil. The corn oil will appear identical in size and color to the fish oil.
Outcomes
Primary Outcome Measures
insulin resistance
Secondary Outcome Measures
Full Information
NCT ID
NCT01857167
First Posted
May 10, 2013
Last Updated
March 11, 2015
Sponsor
Zhejiang University
Collaborators
National Natural Science Foundation of China
1. Study Identification
Unique Protocol Identification Number
NCT01857167
Brief Title
Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhejiang University
Collaborators
National Natural Science Foundation of China
4. Oversight
5. Study Description
Brief Summary
This study is to examine the change of fasting insulin, glucose, insulin sensitivity and related traits in response to the six month treatment of omega-3 fatty acids, including fish oil and flaxseed oil, in Chinese type 2 diabetic patients. Corn oil, rich in omega-6 fatty acids, will be selected as a controlled oil. The investigators hypothesize that omega-3 fatty acids could improve insulin sensitivity and glucose metabolism in Chinese type 2 diabetic patients.
Detailed Description
The insulin resistance will be estimated by a homeostatic model assessment model of insulin resistance (HOMA-IR)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, Insulin Resistance
Keywords
omega-3 fatty acids, randomized controlled trial
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
185 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fish Oil Supplementation
Arm Type
Experimental
Arm Description
Patients will receive fish oil capsules, at a dose of 4g/day. Each 1g capsule will contain 300mg of EPA and 200mg of DHA.
Arm Title
Flaxseed Oil Supplementation
Arm Type
Experimental
Arm Description
Patients will receive flaxseed oil capsule, at a dose of 4g/day. Each 1g capsule will contain 630mg of ALA
Arm Title
Placebo Supplementation
Arm Type
Placebo Comparator
Arm Description
Patients will receive corn oil in the capsules at the same dose as fish oil. The corn oil will appear identical in size and color to the fish oil.
Intervention Type
Dietary Supplement
Intervention Name(s)
Fish Oil Supplementation
Intervention Type
Dietary Supplement
Intervention Name(s)
Flaxseed Oil Supplementation
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Primary Outcome Measure Information:
Title
insulin resistance
Time Frame
180 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Fasting glucose > 7.0 or have diabetes medication;
Male, 35-80 years; female, postmenopausal to 80 years;
Agree to participant in the trial.
Exclusion Criteria:
Deny to sign the informed consent;
type 1 diabetes;
Family history of hypertriglyceridemia or fasting triglyceride>4.56 mmol/L;
Have severe liver disease, kidney disease or cancer;
Participating in the other clinical trial within 30 days;
Other diseases or conditions, for which the doctor of the patients do not agree his or her participating.
Facility Information:
Facility Name
Zhejiang University
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310058
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
22984522
Citation
Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44525. doi: 10.1371/journal.pone.0044525. Epub 2012 Sep 11.
Results Reference
background
PubMed Identifier
27279274
Citation
Zheng JS, Lin M, Fang L, Yu Y, Yuan L, Jin Y, Feng J, Wang L, Yang H, Chen W, Li D, Tang J, Cai W, Shi M, Li Z, Wang F, Li D. Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial. Mol Nutr Food Res. 2016 Oct;60(10):2176-2184. doi: 10.1002/mnfr.201600230. Epub 2016 Jul 12.
Results Reference
derived
Learn more about this trial
Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients
We'll reach out to this number within 24 hrs